Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
167.29
-0.51 (-0.30%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,503,692
Open
167.66
Bid (Size)
166.00 (1)
Ask (Size)
167.29 (3)
Prev. Close
167.80
Today's Range
165.57 - 169.29
52wk Range
130.96 - 182.89
Shares Outstanding
N/A
Dividend Yield
3.54%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
April 25, 2024
AbbVie's Upadacitinib outperforms dupilumab in Phase 3b/4 study for atopic dermatitis treatment, achieving superior efficacy and rapid skin clearance than Dupixent.
Via
Benzinga
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
April 25, 2024
Many fortunes have been made with a fortuitous investment in a biotech stock at the right time. That time might be now.
Via
InvestorPlace
Performance
YTD
+4.67%
+4.67%
1 Month
-6.64%
-6.64%
3 Month
+1.31%
+1.31%
6 Month
+15.21%
+15.21%
1 Year
+3.39%
+3.39%
More News
Read More
Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes
April 23, 2024
Via
InvestorPlace
AbbVie's Options Frenzy: What You Need to Know
April 23, 2024
Via
Benzinga
Buying the Dip in These 3 Undervalued Dividend Stocks
April 22, 2024
Via
The Motley Fool
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today
April 17, 2024
Via
Benzinga
AbbVie's Options Frenzy: What You Need to Know
April 15, 2024
Via
Benzinga
Is AbbVie a Millionaire Maker?
April 14, 2024
Via
The Motley Fool
3 Dividend Kings Down 11% You’ll Regret Not Buying on the Dip
April 22, 2024
Via
InvestorPlace
Why I Keep Buying This Ultra-High-Yielding ETF for Passive Income
April 20, 2024
Via
The Motley Fool
Topics
ETFs
These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?
April 19, 2024
Via
InvestorPlace
The Bad News Heading Into AbbVie's First-Quarter Earnings Report
April 19, 2024
Via
Investor's Business Daily
Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson's Disease Study
April 18, 2024
Via
Benzinga
Smart Money Is Betting Big In ABBV Options
April 12, 2024
Via
Benzinga
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
April 21, 2024
Via
Benzinga
Is Your Botox Real Or Fake? Counterfeit Boxes Circulate For Widely Used Antiwrinkle Treatment, CDC And FDA Investigate Harmful Reactions
April 17, 2024
Via
Benzinga
Exposures
Product Safety
Powell And The Great Indecision
April 16, 2024
Via
Talk Markets
Topics
Economy
Exposures
Economy
Interest Rates
Steady Income, Steady Growth: 7 Blue-Chip Dividend Stocks to Buy Now
April 16, 2024
Via
InvestorPlace
Avalo Therapeutics' Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades
April 16, 2024
Via
Benzinga
Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug
April 15, 2024
Via
Investor's Business Daily
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors
April 12, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
What's Going On AbbVie Stock On Friday?
April 12, 2024
Via
Benzinga
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of AbbVie Inc. (ABBV) on Behalf of Investors
April 12, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024
April 11, 2024
Via
InvestorPlace
The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today
April 11, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.